Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Debora Moitinho Abram
The Modulation of Enzyme Indoleamine 2,3-Dioxygenase From Dendritic Cells for the Treatment of Type 1 Diabetes Mellitus
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Related publications
Indoleamine 2,3-Dioxygenase 1 (IDO1)
Science-Business eXchange
Transient Upregulation of Indoleamine 2,3-Dioxygenase in Dendritic Cells by Human Chorionic Gonadotropin Downregulates Autoimmune Diabetes
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
Amino Acid Deprivation Links BLIMP-1 to the Immunomodulatory Enzyme Indoleamine 2,3-Dioxygenase
Journal of Immunology
Allergy
Immunology
Inhibition of Indoleamine 2,3-Dioxygenase in Dendritic Cells by Stereoisomers of 1-Methyl-Tryptophan Correlates With Antitumor Responses
Cancer Research
Cancer Research
Oncology
Indoleamine 2,3-Dioxygenase Is a Signaling Protein in Long-Term Tolerance by Dendritic Cells
Nature Immunology
Allergy
Immunology
Advances in Indoleamine 2,3-Dioxygenase 1 Medicinal Chemistry
MedChemComm
Organic Chemistry
Molecular Medicine
Pharmacology
Biochemistry
Pharmaceutical Science
Drug Discovery
The Silencing of Indoleamine 2,3-Dioxygenase 1 (IDO1) in Dendritic Cells by siRNA-loaded Lipid Nanoparticles Enhances Cell-Based Cancer Immunotherapy
Scientific Reports
Multidisciplinary
Indole Peroxygenase Activity of Indoleamine 2,3-Dioxygenase
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
The Heme Environment of Recombinant Human Indoleamine 2,3-Dioxygenase
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology